More than 300 volunteers and friends joined Duke Health leaders, faculty, students, and staff for a special weekend May 1-3 highlighting the critical role of philanthropy in driving  innovation, discovery, and patient care. 

Study led by Duke School of Medicine reveals cancer’s weak spot – a protein that helps cells make energy and stops cancer from growing.

Congratulations to the 442 students from the Duke University School of Medicine who graduated on Sunday, May 11, 2025, marking the successful culmination of their hard work and dedication.

Professor of Medicine Michael Hershfield's research has transformed the lives of patients with rare immunodeficiencies and treatment-resistant gout. Now he's made a philanthropic gift to support early career physician-scientists at Duke.

A new, high-resolution atlas of the mouse brain will increase precision in measuring changes in brain structure and make it easier to share results for scientists working to understand neurological diseases such as Alzheimer's.

A Duke University School of Medicine team reimagines a sci-fi classic as real-world biotech that can speed up biological research.

An epic collaboration between neuroscientists at Duke and six other institutions has yielded an AI tool that paves the way for new approaches to treating neurological disorders.

New strategy could change how we design drugs—especially the large and polar ones that were once too big to work.

Researchers propose a "treatable fetal findings list" that identifies genetic conditions that can be detected with prenatal testing and treated in utero or in the first week of life.

Sabrina Lewandowski was diagnosed with a usually fatal form of glioblastoma that many centers would have considered untreatable. But the research-intensive team at Duke took a different approach — and 23 years later, she's living her life and raising her 13-year-old daughter.